← All Sponsors
SPONSOR

Xynomic Pharmaceuticals, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Renal Cell Carcinoma
NCT03592472 Phase 3
Recruiting

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Renal Cell Carcinoma
United States, China, Italy View Trial →